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Background: Gene Ontology (GO) enrichment analysis remains one of the most common methods for hypothesis
generation from high throughput datasets. However, we believe that researchers strive to test other hypotheses
that fall outside of GO. Here, we developed and evaluated a tool for hypothesis generation from gene or protein
lists using ontological concepts present in manually curated text that describes those genes and proteins.
Results: As a consequence we have developed the method Statistical Tracking of Ontological Phrases (STOP) that
expands the realm of testable hypotheses in gene set enrichment analyses by integrating automated annotations
of genes to terms from over 200 biomedical ontologies. While not as precise as manually curated terms, we find
that the additional enriched concepts have value when coupled with traditional enrichment analyses using curated
terms.
Conclusion: Multiple ontologies have been developed for gene and protein annotation, by using a dataset of both
manually curated GO terms and automatically recognized concepts from curated text we can expand the realm of
hypotheses that can be discovered. The web application STOP is available at http://mooneygroup.org/stop/.Background
High throughput experimentation such as gene expression
microarrays, next generation sequencing or proteomics
enables the interrogation of many thousands, or even mil-
lions, of data points simultaneously. Comparison between
these experiments (such as a phenotype and control)
enables identification of gene or protein sets of interest in
a hypothesis free manner. To stimulate generation of test-
able, explanatory hypotheses for experimental validation
from these sets of genes, researchers will often apply Gene
Set Enrichment Analysis (GSEA) [1] or concept enrich-
ment analysis using controlled vocabulary terms. Term
enrichment analysis, which refers to the search for ontol-
ogy terms that occur more in a given gene list when com-
pared with a background gene set, can be used to generate
new scientific hypotheses. Gene Ontology (GO) [2,3],* Correspondence: smooney@buckinstitute.org
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reproduction in any medium, provided the orarguably the most commonly used ontology in basic re-
search, consists of a collection of three non-overlapping
controlled vocabularies that describe molecular functions,
biological processes and cellular components. There are
now more than 50 GO-based enrichment analysis tools
available. Examples of such functional analysis tools
are BiNGO [4] or GOEAST [5] , which solely utilize gene
ontology (GO) for their analyses. Other approaches, such
as ClueGO [6], DAVID [7] and GeneWeaver [8], incorpor-
ate larger range of sources, such as disease ontologies,
phenotype ontologies or common pathways. However, all
of them rely on predefined gene annotations and thus are
limited to biomedical domains that have curated annota-
tions. Baumgartner, et al. [9] presented an analysis that
demonstrated how manually curated annotations can
never keep pace with novel scientific discoveries, and
argued that text-mining based methods need to be
adopted to keep pace with the rising volume of literature.
For example, an incredible amount of established know-
ledge about genomes and proteomes is available through
NCBI Entrez Gene [10] and UniProt [11], but thel Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Wittkop et al. BMC Bioinformatics 2013, 14:53 Page 2 of 10
http://www.biomedcentral.com/1471-2105/14/53concepts mentioned in the textual descriptions of genes
and proteins in these resources are not part of any statis-
tical enrichment analysis. We believe in a hybrid approach
of testing manually curated terms along with automatic-
ally recognized concepts from curated text will result in
more hypotheses and therefore be more useful to the
researcher.
Large-scale annotation of all the known genes and
expressed proteins in an organism’s genome is a complex
and arduous task. To this end, biology and medicine have
created and manage discipline-specific structured
ontologies that are suitable for gene or protein annotation.
Although these ontologies are publicly available, for in-
stance via the National Center for Biomedical Ontology
[12,13] or the EBI Ontology Lookup Service [14,15] and
provide valuable information about connections between
different biological concepts, only a small fraction of these
ontologies are used for gene and protein annotation and
therefore a relatively small amount of annotations are ac-
tually available for use in enrichment analysis methods.
The quality of results from term enrichment analysis
is naturally dependent on the quality of the annotations
underlying the analysis. Therefore term enrichment ana-
lysis should only use high quality annotations, such as
the human-curated annotations from Ingenuity Pathway
Analysis (IPA) (http://www.ingenuity.com/) or from a
highly restricted subset of GO of experimentally
validated and published annotations. However, many
genes do not have annotations of this quality, and there-
fore the results of enrichment analysis can be highly
incomplete. On the other end of the spectrum, including
automated annotations based on criteria such as computa-
tional prediction using sequence similarity would result in
a richer but less accurate set of annotations and hence less
reliable results from term enrichment analysis. In this
paper, we propose a middle ground that combines high
quality human-curated gene descriptions with automated
assignment of annotation terms based on those descrip-
tions. We use the Stanford National Center for Biomedical
Ontology (NCBO) Annotator [16], which provides anno-
tations with terms from over 200 publicly available
biomedical ontologies, to automatically annotate a gene or
protein based on the corresponding Entrez Gene or
UniProt textual description. The text description is used
as the basis on which the NCBO Annotator provides
ontological terms that could annotate the gene or protein
We find that automated annotations generated in this
manner reliably recover the known annotations already
present in the text record (such as GO terms or OMIM
[17] terms), and we find that we are able to annotate
with a wide spectrum of concepts not available in any
currently used ontology enrichment tools. Additionally,
we are able to identify GO terms that are present in
curated text that are not currently formerly annotated tothese genes or proteins, and many of these examples are
bona fide annotations. Overall, our approach is able to
annotate proteins with 524,304 terms from across 291
ontologies; and a vast majority of these terms are not
part of the GO.
In the following, we will demonstrate the advantages
of using automatic annotations that are based on manu-
ally curated textual descriptions, by extending our previ-
ous RANSUM approach [18] to enable analysis of genes
and protein concepts. We will first describe the STOP
workflow, which allows a researcher fast and easy statis-
tical analyses of gene sets using up-to-date information
of genes and proteins from the most widely used model
organisms and human. We will further demonstrate how
automatically derived annotations contain valuable infor-
mation that is not currently present in the GO, without
diminishing the value of manually curated GO enrich-
ment analysis. Therefore, we compare our annotations
against GO and highlight examples of gene-to-term
annotations that are likely to be correct but not present
in official GO annotations. Finally we describe two
use-cases: (1) proteins that are direct protein interaction
partners of the huntingtin protein and (2) known
Parkinson’s disease genes. We use these sets of proteins
to demonstrate how STOP can reveal interesting
enriched concepts that improve the understanding of
functional traits implied by gene sets.
Results
Term enrichment with automatically derived annotations
Here, we present STOP (Statistical Tracking of Ontological
Phrases), a web resource that utilizes automatic annotation
and term enrichment analyses to generate novel insights
into common traits of sets of genes. In contrast to com-
monly used tools for the task of gene set enrichment ana-
lysis, STOP does not limit itself to predefined annotations
and a few controlled vocabularies, but uses up-to-date in-
formation (curated text) about genes to map them to terms
from all 291 ontologies provided by the National Center
for Biomedical Ontology (NCBO). Results from an analysis
with STOP annotations are presented in a web interface
that allows easy navigation and identification of concepts
that summarize the input set of genes; thus helping
researchers interpret and understand experimental results
to create novel hypotheses.
The computational pipeline underlying the STOP
backend as well as the real time enrichment analysis
provided by the STOP frontend via a web interface are
explained graphically in Figure 1.
We implemented a fully automatic import process that
can be executed at very frequent intervals (currently
once a month) to always provide the latest, state-of–the
-art information about genes. This process of populating
our local database includes:
Figure 1 Overview of the computational workflow of STOP. The left side illustrates the backend of the STOP software, i.e. the automatic
annotation pipelin: (1) The genome and proteome of all included species is retrieved from UniProt and Entrez Gene respectively and
subsequently (2) descriptions for all genes/proteins are collected from UniProt and Entrez Gene and finally (3) submitted to the NCBO annotator
web service. The information is stored in a MySQL database and can be accessed by the frontend, which is displayed here on the right side. The
real-time analysis pipeline requires a list of genes as input and calculates for each term of the 200+ ontologies whether it is enriched in the given
gene list. The results are subsequently presented as a tag cloud or in list form.
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proteome of the 6 widely used model organisms Mus
musculus, Rattus norvegicus, Drosophila
melanogaster, Caenorhabditis elegans, Saccharomyces
cerevisiae and Escherichia coli and Homo sapiens via
UniProt and NCBI Entrez Gene .
2. Search, download and filtering of descriptive text for
each gene/protein using NCBI Entrez Gene and
UniProt.
3. Annotation of the genes/proteins to terms from all
ontologies currently present in the NCBO Bioportal
database, using the Annotator Web service.
STOP currently uses over 667,258,930 annotations of
226,298 genes and 200,047 proteins from 7 organism
(H. sapiens, M. musculus, R. norvegicus, D. melanogaster,
C. elegans, S. cerevisiae, and E. coli) that come from
524,304 terms across 291 ontologies. The included
ontologies can provide general information as in GO and
NCI Thesaurus [19], or can be more specific as, forinstance, in the Disease Ontology [20], Pathway Ontology
[21], or Human Phenotype Ontology [22].
STOP has been optimized for fast processing to com-
pute and display enriched terms from 291 ontologies in
a matter of seconds. The resulting term list can still be
overwhelming. Therefore, we: (i) Remove redundant in-
formation by combining terms with the same name; (ii)
Implement filtering methods that can display results
from selected ontologies, ontology categories, or terms
that match user specific key words; (iii) Identify a list of
41 highly informative ontologies that can be accessed as
“Preferred” using the ontology category filter; (iv)
Visualize the enriched terms as a sorted table or term
cloud. We further ease usage of our web interface by
utilizing all gene identifier mappings for genes and
proteins as available from NCBI Entrez Gene and Uni-
Prot respectively. To use STOP a researcher simply has
to: (1) copy + paste their list of genes or protein (delim-
ited via whitespace, comma, semicolon, tab or newline),
(2) select the species, the background set of genes and
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down menus, and (3) press the submit button. The
STOP web interface is available at http://mooneygroup.
org/stop.
Comparing gene ontology with automatic annotations
As GO is still the standard ontology when analyzing
gene sets for their functions, we compared the official
GO annotations to those we automatically derive within
STOP for this ontology. We obtain the gold standard
GO annotations for proteins from UniProt and for genes
from Entrez gene (gene2go file). We further compared
gene-based annotations with annotations from the re-
spective species-specific databases: GOA [23] (human),
FlyBase [24] (fly), WormBase [25] (worm), RGD [26] (rat),
SGD [27] (yeast), EcoCyc [28] and MGI [29] (mouse)
obtained via http://www.geneontology.org. The results are
slightly lower in Recall and Precision, probably due to
database differences between Entrez Gene and the
species-specific sites. In this analysis we consider each
gene in our background that is also found in GO, i.e.
genes that have at least one GO term annotation. For each
such gene we calculate precision and recall and determine
the average of these values to evaluate the overall equality
between these two approaches. The precision for one spe-
cific gene is the ratio of GO terms that are annotated in
both the gold standard and our annotation to that gene
(true positives) divided by all annotations that we predict
for this gene (true positives + false positives). The average
precision for an organism is the average of all precision
for all genes in that organism. As expected we achieve
high recall values ranging from 0.96 to 1 for the different
species except E.coli. When comparing our annotations
with E.coli we see big differences, which seem to be rooted
in the limited GO annotations that are present in Entrez
Gene (our annotation source) for E. coli. The generally
high recall values are due to the fact that GO terms are
part of the text that comprises our input for the
annotation process. Missing terms are easily explained by
different versions and changes in GO. The lower precision
shows that STOP finds several novel annotations that are
currently not in GO and thus are counted as false posi-
tives in this evaluation. We find however, that along actual
false positives many of these new annotations make sense
and probably should be included in GO, see below for
some examples. For the annotation process we integrated
GO annotations from UniProt and Entrez Gene while the
comparison has been performed on the most recent ver-
sion obtained from UniProt GOA, Entrez Gene and
http://www.geneontology.org/.
The results (presented in Table 1) show that for most
genes we identify already known GO terms and add sev-
eral annotations that are not present in the manual
annotations. We found several examples where genes orproteins have functions associated with them that are
only described in UniProt/Entrez Gene but are not yet
associated with relevant GO terms. One example is the
human protein liver carboxylesterase 1 (P23141). STOP
associates this protein with the GO term ‘cocaine meta-
bolic process’ (GO:0050783). This association is not
listed on the GO annotations website. This association
was identified from a title for a reference paper for the
protein, “Structural basis of heroin and cocaine metabol-
ism by a promiscuous human drug-processing enzyme”
[30]. Another example can be found in the C. elegans
protein (Q27539) ATP-dependent Clp protease proteo-
lytic subunit 1, mitochondrial. STOP annotated this
protein with the GO concept mitochondrial unfolded
protein response’ (GO:0034514), however this concept
was not in the GO annotations. The concept was identi-
fied from one of the references associated with this protein,
“ClpP mediates activation of a mitochondrial unfolded pro-
tein response in C. elegans” [31].
Using STOP to improve understanding of Huntington’s
disease
In order to assess the functional utility of STOP, we
selected a set of proteins from the Human Protein Refer-
ence Database (HPRD) that are known to directly inter-
act with the human Huntingtin gene (HTT) [32]. HTT
is of particular interest in neurodegeneration because it
is prone to polyglutamine expansion, the degree
of which correlates to the severity of the development of
Huntington’s disease, a devastating neurodegenerative
disease. The list of interacting proteins, which is stored
on the gene level in HPRD, consists of 59 genes
(excluding HTT) serves as a test case for STOP here
(see Additional file 1). Since the interactions are on the
protein level UniProt/SwissProt IDs were used in the
analysis, and the SwissProt Human database was used as
the background for the enrichment analyses. As an add-
itional point of comparison, the same list of proteins was
submitted to DAVID and all enriched gene ontology
(GO) annotations were retrieved using the “GO_all”
database. The analysis using DAVID returned a typical
list of enriched GO categories (Figure 2A). Among the
terms that can be associated directly with what is known
about Huntington’s disease were for example protein
complex assembly, induction of apoptosis and terms
associated with cell death. Biologically, each of these
terms describes at least some part of what little is known
about the function of HTT. However, these (and the
other terms) don’t give much information about the
gene set as a whole. If, for instance, one were to submit
this gene list not knowing how or if the genes had any
shared biological relevance, the results of the GO enrich-
ment analysis would be difficult to interpret and would
likely not contribute to the understanding of the dataset.
Table 1 Summary of comparison between STOP and GO annotations
Species Annotation source/gold standard Recall Precision F-measure
human
Entrez Gene/Entrez Gene 0.993 0.678 0.806
Entrez Gene/GOA 0.979 0.674 0.798
UniProt/GOA 0.998 0.608 0.756
mouse
Entrez Gene/Entrez Gene 0.990 0.791 0.879
Entrez Gene/MGI 0.990 0.791 0.879
UniProt/GOA 0.999 0.746 0.854
rat
Entrez Gene/Entrez Gene 0.987 0.724 0.835
Entrez Gene/RGD 0.959 0.713 0.818
UniProt/GOA 0.999 0.736 0.847
fly
Entrez Gene/Entrez Gene 0.987 0.767 0.863
Entrez Gene/FlyBase 0.978 0.762 0.857
UniProt/GOA 0.992 0.751 0.855
worm
Entrez Gene/Entrez Gene 0.998 0.783 0.878
Entrez Gene/WormBase 0.998 0.783 0.878
UniProt/GOA 0.999 0.788 0.881
yeast
Entrez Gene/Entrez Gene 0.994 0.798 0.885
Entrez Gene/SGD 0.994 0.798 0.885
UniProt/GOA 0.998 0.630 0.773
E. coli
Entrez Gene/Entrez Gene 1.000 0.611 0.758
Entrez Gene/EcoCyc 0.340 0.354 0.347
UniProt/GOA 0.964 0.826 0.890
Annotations based on Entrez Gene descriptions are compared against the gene2go annotations from Entrez Gene and species-specific databases where the
annotations have been downloaded from http://www.geneontology.org, and STOP annotations based on UniProt descriptions are compared against GOA
annotations. Recall and Precision are calculated for each gene and subsequently averaged. The F-measure is the harmonic mean of these average Recall and
Precision values.
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STOP, the results were more diverse. For the pur-
poses of this test case, the results of the STOP en-
richment analysis were filtered using only terms
from the “Preferred” ontologies (see Additional file
2), which helps to refine the output to more bio-
logically useful annotations (Figure 2B). In this case,
the top 30 enriched annotations include terms simi-
lar to those in the GO analysis such as protein bind-
ing or cellular component organization. However, the
results also include more descriptive terms such as
Huntington’s Disease, huntingtin, Transferases, drug
interaction, and solute carrier family 6 (neurotrans-
mitter transporter, serotonin). Thus, the STOP ana-
lysis correctly identified this gene list as being
associated with Huntington’s disease, neuron-related
processes, and specific disease pathways (histone
deaceltylases). It is important to note that the HTT
gene was not a part of the submitted gene list in ei-
ther analysis.Application of STOP to Parkinson’s disease
To further validate the utility of STOP, we applied it to
genes and proteins associated with Parkinson’s Disease
(PD). All proteins in UniProt that are associated with
PD were identified in the PhenoPred resource [33],
resulting in 14 human proteins (see Additional file 3).
STOP was applied on this list resulting in many
enriched terms using Benjamini-Hochberg for correc-
tion of multiple hypotheses and UniProt/SwissProt as
background (Results for the top 30 enriched categor-
ies in the preferred set of ontologies can be seen in
Figure 2C). Not surprisingly the top term was Parkin-
son’s Disease (p < 1.87 × 10-25), which was found in 20
ontologies (6 preferred ontologies). Other terms
included Basal Ganglia Diseases (9.86 × 10-21), Tremor
(2.39 × 10-22), Movement Disorders (1.50 × 10-17), Sub-
stantia Nigra (1.24 × 10-16), Brain Diseases (3.02 × 10-13),
Age (7.79 × 10-14), Dopamine (5.74 × 10-12), Neuron
(4.80 × 10-11), and many others. All terms appear to
be relevant, with possible false positives been related
Figure 2 (See legend on next page.)
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Figure 2 Top 30 enriched terms for DAVID and STOP analysis of Htt interacting proteins and STOP analysis of Parkinson’s genes. Fifty-
nine genes from the HPRD database known to interact with the Human Huntingin (HTT) gene were analyzed using STOP and DAVID (GO). 14
proteins known to be involved in Parkinson’s disease were analyzed with STOP. (A) The list of HTT interacting proteins was submitted to DAVID,
and enrichment analysis carried out with GO_all using SwissProt Human as the background. The top 30 annotations are shown. (B) The same
proteins were also submitted to STOP with the same background, and the results were limited to annotations from the preferred ontologies. (C)
The Parkinson’s related proteins were similarly analyzed with STOP; again limited to annotations from the preferred ontologies. The top 30
categories are shown along with their significance. Significance is defined as the –log(Benjamini-Hochberg corrected p-values). For reference,
p = 0.01 is equivalent to 2.
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Alzheimer Disease (1.20 × 10-19) or Spinocerebellar
Ataxia 17, (CAG)n Expansion (2.60 × 10-22). Less sig-
nificant are terms associated with pathology but are too
general to be useful such as Lab (8.59 × 10-9) or Patients
(9.88 × 10-7).
Discussion
Some ontological annotations don’t make scientific sense,
for example, human genes and proteins that are automat-
ically annotated with terms from the C. elegans Phenotype
Ontology. Given that, the philosophy of our approach was
to capture the widest possible number of term annota-
tions, in a hypothesis-free manner, regardless of the
source. Since all examination of these annotations is
through statistical enrichment, we believe that falsely dis-
covered annotations will not be statistically enriched after
multi hypothesis correction. Users, of course, are allowed
to select out any term sets in real time on the website, pre-
venting the presence of spurious terms.
Using automated annotations derived from text can,
however, lead also to false positive annotations. An ex-
ample we observed, was that results for protein sets that
were obtained from interaction data often had the terms,
“mint”, “menthol”, and “vascular plant” enriched. We
could trace this to the interaction database MINT [34]
which was part of the descriptive text of all proteins,
that had an interaction stored in that database. As a con-
sequence we exclude common database names from the
gene descriptions. On the other hand, unrelated terms
can have a true meaning that can only be detected with
automated text-based methods. In an analysis of a set of
genes that are involved in Parkinson’s disease, we
observed the term “Australia” as enriched (using Entrez
Gene, p < 3.03 × 10-8). Originally assuming this to be a
false positive we identified the source as a research
group in Australia that is leading in Parkinson’s research
due to a highly cited manuscript with Australia men-
tioned in the title. Although not biologically relevant,
this example shows that automated annotations are cap-
able of detecting relations that would otherwise remain
undetected.
Due to the import process, the STOP application com-
pletely depends on the ontologies that are made availablethrough and the annotator web service that is provided by
NCBO. However, the NCBO constantly expands their
database of available ontologies and adds mapping infor-
mation between terms of different ontologies. STOP takes
advantage of this growing resource by regularly re-
annotating (about once a month) the list of genes with
up-to-date gene descriptions.
Interestingly, we found that in many cases proteins
would be annotated with GO terms that were not found
in the gold standard GO annotation database from the
GO consortium website. We pursued this and found
that these annotations were often correct. While this is
out of the purview of the STOP method, it suggests that
curators would do well to identify term text and fold
them into their own annotations.
Conclusion
We have constructed a tool that substantially broadens
the hypotheses that can be generated with enrichment
analysis using automatically created annotations. We find
that these annotations are able to identify existing known
concepts in the text. Users can download our species spe-
cific annotation datasets and perform enrichment analysis
on our website with a list of gene and protein IDs.
Enriched and depleted terms can be filtered by ontology
or ontology type. Furthermore, annotations can be down-
loaded into a spreadsheet for later use. In the end, STOP
enables experimental research projects to identify hypoth-
eses for gene and protein sets using a concept space
that is far larger than GO or OMIM, thereby improving




In order to build the necessary components to perform
enrichment analysis, the following was performed. First, a
list of the genes and proteins for each genome and prote-
ome was compiled using Entrez Gene and UniProt. Using
a web service, the text descriptions for each gene or pro-
tein were collected. This text was then used as input into
the NCBO Automated Annotator, where ontological con-
cepts were annotated upon that text. This is then repeated
for each list of genes and proteins for each species,
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and E. coli. Detailed description of these steps are below.
1.Collect whole genome/proteome gene/protein lists
The first step is to identify all genes/proteins in the
genome/proteome of all species. The genes in a
genome are determined using the Entrez Gene
database and the proteome is similarly determined by
UniProt using all proteins that contain the “whole
proteome” keyword. We provide subsets of the
genomes/proteomes as predefined background for
the statistical analysis: (1) all Entrez Gene genes, (2)
only RefSeq reviewed/validated genes, and (3) only
protein coding genes as gene backgrounds and (1)
UniProt/Swissprot and (2) UniProt/Tremble as
protein backgrounds. However, we annotate all
genes/proteins in the genomes/proteomes as
described in the subsequent steps.
2.Collect descriptive text for each gene/protein
There are several publicly available databases that
provide information about genes and proteins. The
text descriptions for genes are downloaded from the
FTP site of the NCBI Entrez Gene database and the
text descriptions for proteins are downloaded from
the UniProt database. The Entrez Gene text is
downloaded as binary file and converted into XML
format The descriptive text for proteins is obtained
in TXT format from UniProt. We extract valuable
information from both resources while removingFigure 3 The STOP website showing results in a bar graph. On the left th
on the right the enriched categories for the Huntingtin primary interactors thunnecessary informations such as author names
that could lead to false positive annotations. For
Entrez Gene the descriptive text includes a gene
summary, short descriptive texts from GeneRIF
and known annotations and interactions. For
UniProt the text for each protein has a summary
that describes the proteins’ function, a list of
publication titles that are associated with a protein
and already known annotations and keywords. We
store the type of text (e.g. gene summary, GeneRIF, or
publication title) and the text itself to being able
to add evidence to obtained annotations in future
releases of STOP.
3.Annotate concepts upon text
All text describing genes and proteins is read by the
NCBO Automated annotator. The NCBO annotator
uses a library of terms and their synonyms from over
200 biomedical ontologies. It applies the string
matching algorithm MGrep on our input text and
finds all exact matches of available term names or
known synonyms thereof in the submitted text. It
filters known stopwords such as “the”, “and”, “is” etc.
and each annotation is propagated to the root, i.e. if
a text is annotated to a term it is automatically
annotated to all its parents following the “is_a”
relationship in the respective ontology. The available
parameters of the NCBO Annotator are specified in
Additional file 4 list of available ontologies which we
can annotate to, are listed in Additional files 2. Note,e navigation interface with previously performed jobs is shown and
at are present in our list of preferred networks are displayed.
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terms across ontologies, we decided to leave out this
option to allow for a more independent annotation of
each ontology.Since each input text is associated with
a gene/protein we obtain annotations for genes/
proteins from the annotator. Subsequently, we simply
remove redundant annotations and store each
annotation in a local database which then can be
accessed by our web frontend and analysis backend.
An example of this workflow is shown in Figure 1.Computing enrichment analysis
We apply the most widely used hypergeometric test to
identify concepts that are overrepresented with respect to a
background set of genes. A user may choose to provide
such a set, or use one of our predefined background sets
for genes ((1) Entrez Gene, (2) RefSeq reviewed/validated,
of (3) protein-coding) or proteins (UniProt/Swissprot or
UniProt/Tremble). All analyses are done separately for each
ontology, i.e. multiple hypothesis correction is done on an
individual ontology basis and only those terms with at least
one input gene annotated to it are analyzed and contribute
to the multiple hypothesis corrections. Let in the following
n denote the number of genes in our study and m the num-
ber of genes in the background with at least one annotation
in the respective ontology, i.e. genes that have no annota-
tion in that ontology are ignored. Further let nt and mt be
the number of genes annotated to a term in the study set
and the background respectively. The p-value p(t) repre-
senting the likelihood that a term t has annotations to at
least as many genes as we observe in our list of genes is cal-
culated using the one-tailed version of Fisher’s exact test
[35], also known as hypergeometric test:
p tð Þ ¼











In order to correct for multiple hypotheses, a user
may choose between the three most commonly used
methods Bonferroni [36], Bonferroni-Holm [37], and
Benjamini-Hochberg [38]. STOP applies this correction
per individual ontology to guarantee consistent results
that are independent of the user’s choice of ontologies.
A term is reported as enriched if the adjusted p-value is
below a significance threshold of 0.05. STOP reports
only terms that have a significant corrected p-value and
at least 3 genes annotated to it.
Implementation
The STOP website was constructed using DRUPAL and
requires a user to submit an email address or create anaccount. All annotations are stored locally in a MySQL
database and the enrichment analysis back-end as well as
the import process have been implemented in JAVA. A job
usually finishes in under a minute (Figure 3).
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Additional file 2: List of all ontologies that are available for the
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